Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Dermatology and Therapy
|
May 10, 2024
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting
Sarah Alulis, Nicoletta Bernardini, Martina Burlando, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
March 10, 2015
Psoriasis awareness among Italian patients: results of a nationwide survey
Federico Bardazzi, Paolo Amerio, Giuseppe Amoruso, et al.
Expert Opinion on Biological Therapy
|
October 11, 2013
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
Clara De Simone, Paolo Amerio, Giuseppe Amoruso, et al.
Dermatologic Therapy
|
May 31, 2022
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)
Piergiorgio Malagoli, Paolo Dapavo, Giulia Pavia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2022
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
The Journal of Dermatological Treatment
|
January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
The Journal of Dermatological Treatment
|
April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Stefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Dermatology and Therapy
|
May 21, 2023
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
Giovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Psoriasis (Auckland, N.Z.)
|
August 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years
Luca Mastorino, Paolo Dapavo, Martina Burlando, et al.
International Journal of Dermatology
|
January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort
Riccardo Viola, Luca Mastorino, Matteo Megna, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Dermatology and Therapy
|
May 10, 2024
OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting
Sarah Alulis, Nicoletta Bernardini, Martina Burlando, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia
|
March 10, 2015
Psoriasis awareness among Italian patients: results of a nationwide survey
Federico Bardazzi, Paolo Amerio, Giuseppe Amoruso, et al.
Expert Opinion on Biological Therapy
|
October 11, 2013
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
Clara De Simone, Paolo Amerio, Giuseppe Amoruso, et al.
Dermatologic Therapy
|
May 31, 2022
Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)
Piergiorgio Malagoli, Paolo Dapavo, Giulia Pavia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2022
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
The Journal of Dermatological Treatment
|
January 27, 2025
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis)
Mario Valenti, Luciano Ibba, Sara Di Giulio, et al.
The Journal of Dermatological Treatment
|
April 7, 2023
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy
Stefano Dastoli, Maria Passante, Francesco Loconsole, et al.
Dermatology and Therapy
|
May 21, 2023
Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus
Giovanni Damiani, Paolo Amerio, Federico Bardazzi, et al.
Psoriasis (Auckland, N.Z.)
|
August 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years
Luca Mastorino, Paolo Dapavo, Martina Burlando, et al.
International Journal of Dermatology
|
January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort
Riccardo Viola, Luca Mastorino, Matteo Megna, et al.
Page
of 8